Abbvie (ABBV) Profit Margin (2012 - 2026)
Abbvie (ABBV) profit margin from Mar 31, 2012 to Mar 31, 2026. The current Abbvie (ABBV) profit margin is 4.63%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Abbvie (ABBV)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 6.91% | -9.01% |
| 2024 | 7.59% | -15.18% |
| 2023 | 8.95% | -56.09% |
| 2022 | 20.39% | -0.73% |
| 2021 | 20.54% | +103.80% |
| 2020 | 10.08% | -57.47% |
| 2019 | 23.69% | +36.46% |
| 2018 | 17.36% | -47.94% |
| 2018 | 33.35% | +39.23% |
| 2018 | 23.96% | -31.71% |
| 2018 | 35.08% | +86.42% |
| 2017 | 18.82% | -19.30% |
| 2017 | 23.32% | -15.45% |
| 2017 | 27.58% | +5.38% |
| 2017 | 26.17% | +12.71% |
| 2016 | 23.22% | -6.54% |
| 2016 | 24.84% | -0.44% |
| 2016 | 24.95% | +9.80% |
| 2016 | 22.73% | +0.99% |
| 2015 | 22.50% | +7.96% |
| 2015 | 20.84% | -16.45% |
| 2015 | 24.95% | +23.04% |
| 2015 | 20.28% | +128.15% |
| 2014 | 8.89% | -11.84% |
| 2014 | 10.08% | -54.77% |
| 2014 | 22.29% | +3.78% |
| 2014 | 21.48% | -2.24% |
| 2013 | 21.97% | +6.15% |
| 2013 | 20.70% | -9.08% |
| 2013 | 22.76% | +1.79% |
| 2013 | 22.36% | -22.09% |
| 2012 | 28.70% | -18.37% |
| 2012 | 35.16% | +24.68% |
| 2012 | 28.20% | +33.27% |
| 2012 | 21.16% | +7.52% |
| 2011 | 19.68% | N/A |
Comparison Abbvie (ABBV) profit margin with competitors
Abbvie (ABBV) profit margin is 4.63%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +982.52% |
| LLY | Lilly(Eli) & Company | 37.36% | +706.44% |
| GILD | Gilead Sciences Inc | 29.04% | +526.85% |
| NVS | Novartis AG | 23.34% | +403.81% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +402.94% |
| GSK | GSK Plc | 22.77% | +391.50% |
| JNJ | Johnson & Johnson | 21.76% | +369.70% |
| AMGN | AMGEN Inc | 21.11% | +355.67% |
| AZN | Astrazeneca plc | 20.15% | +334.95% |
| PFE | Pfizer Inc | 18.59% | +301.28% |
| SNY | Sanofi | 14.35% | +209.75% |
| BIIB | Biogen Inc | 12.89% | +178.24% |
| OGN | Organon & Company | 10.00% | +115.86% |
| GRFS | Grifols SA | 4.29% | -7.40% |